China Universal Asset Management Co., Ltd.
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1906594
SHANGHAI, F4
Position in VRTX
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$23,974,673
+$4,370,674 QoQ
Shares Held
48,265
+9.9% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
1.47%
of 13F equity value
Holder Rank
#238
of 1,732 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026China Universal Asset Management Co., Ltd. holds $180,189,557 across 240 Biotechnology names. VRTX ranks #1 (13.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
48,265 | $23,974,673 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
19,498 | $12,157,782 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
25,269 | $7,606,727 | |
| 4 | RPRX |
Royalty Pharma plc
|
120,547 | $6,759,070 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
33,835 | $6,336,618 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
76,302 | $6,049,985 | |
| 7 | MRNA |
Moderna, Inc.
|
63,149 | $4,422,324 | |
| 8 | ARGX |
Argenx SE
|
4,642 | $4,306,708 |
All Filings in VRTX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,974,673 | 48,265 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $19,603,999 | 43,902 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $21,782,587 | 48,047 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $17,668,446 | 45,114 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $19,706,778 | 44,265 | Shares | Sole | 2025-08-28 | |
| 2025-03-31 | $23,691,214 | 48,866 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $21,093,828 | 52,381 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $22,983,788 | 49,419 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $16,337,235 | 34,855 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $21,348,606 | 51,072 | Shares | Sole | 2024-05-21 | |
| 2023-12-31 | $15,497,219 | 38,087 | Shares | Sole | 2024-05-22 | |
| 2023-09-30 | $7,360,960 | 21,168 | Shares | Sole | 2024-05-22 | |
| 2023-06-30 | $6,269,276 | 17,815 | Shares | Sole | 2024-05-22 | |
| 2023-03-31 | $5,581,149 | 17,714 | Shares | Sole | 2024-05-22 | |
| 2022-12-31 | $4,847,461 | 16,786 | Shares | Sole | 2024-05-22 | |
| 2022-09-30 | $6,792,318 | 23,459 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $6,883,847 | 24,429 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $8,361,217 | 32,039 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $3,294 | 15 | Shares | Sole | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||